These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 20512891

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Does normalisation improve the diagnostic performance of apparent diffusion coefficient values for prostate cancer assessment? A blinded independent-observer evaluation.
    Rosenkrantz AB, Khalef V, Xu W, Babb JS, Taneja SS, Doshi AM.
    Clin Radiol; 2015 Sep; 70(9):1032-7. PubMed ID: 26126712
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Non-Gaussian water diffusion kurtosis imaging of prostate cancer.
    Suo S, Chen X, Wu L, Zhang X, Yao Q, Fan Y, Wang H, Xu J.
    Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826
    [Abstract] [Full Text] [Related]

  • 8. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA, Tung GA, Grand DJ, Pezzullo JA, Machan JT, Renzulli JF.
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [Abstract] [Full Text] [Related]

  • 9. The value of diffusion-weighted MRI for prostate cancer detection and localization.
    Yağci AB, Ozari N, Aybek Z, Düzcan E.
    Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
    Ding K, Yao Y, Gao Y, Lu X, Chen H, Tang Q, Hua C, Zhou M, Zou X, Yin Q.
    Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.
    Latifoltojar A, Dikaios N, Ridout A, Moore C, Illing R, Kirkham A, Taylor S, Halligan S, Atkinson D, Allen C, Emberton M, Punwani S.
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):343-51. PubMed ID: 26195470
    [Abstract] [Full Text] [Related]

  • 16. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, Zhao WF, Yang ZH, Zhong CY, Li GZ.
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [Abstract] [Full Text] [Related]

  • 17. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
    Lim HK, Kim JK, Kim KA, Cho KS.
    Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
    Kim CK, Park BK, Lee HM.
    J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.